Inequality in Quality: Addressing Socioeconomic, Racial, and Ethnic Disparities in Health Care
Article Abstract:
Most quality performance measures in the healthcare industry do not address the socioeconomic and racial disparities in health care in the US. These disparities have been extensively documented yet this information has not been included in organizational quality improvement plans. Researchers discuss several ways this can be done.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Health insurance and mortality: evidence from a national cohort
Article Abstract:
The death rate may be higher among individuals who do not have health insurance than those who have private health insurance. Among 4,882 individuals over 25 years old who were surveyed between 1971 and 1975, 699 had no health insurance and 4,183 had private health insurance. Eighteen percent of the uninsured individuals had died by 1987, compared with 10% of the insured individuals. The effect of insurance status on death rate was comparable to that of education, income, employment status and self-reported health status. The death rate may be higher among uninsured individuals because they have less access to medical care. The medical care that they do receive may be of lower quality than that received by insured individuals.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling
Article Abstract:
The nicotine patch appears to be cost-effective when combined with physician counseling and should be covered by health insurance. Researchers used a decision model based on clinical reports of the effectiveness of nicotine patches to estimate the cost of the patch per quality-adjusted years of life saved (QALY). The patch was estimated to cost $111.90 per month. The incremental cost-effectiveness ranged from $4,390 to $10,943 per QALY depending on the age and sex of the person. Younger men benefited more than younger women but older women benefitted more than older men. The cost-effectiveness of nicotine patches compares favorably with screening and treatment for hypertension, which ranges from $14,185 to $39,867 depending on the age and sex of the person. The nicotine patch was twice as cost-effective as 2 milligram nicotine gum and equally as effective as the 4 milligram gum.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
- Abstracts: Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults
- Abstracts: Calcification of the Aortic Arch: Risk Factors and Association With Coronary Heart Disease, Stroke, and Peripheral Vascular Disease
- Abstracts: Patient Characteristics and ICU Organizational Factors That Influence Frequency of Pulmonary Artery Catheterization